Raydiant Oximetry Raises $5M in Series A2 Financing
Summary
Fogarty Innovation, a nonprofit educational incubator for medical technology companies, announced today that its graduate, Raydiant Oximetry, Inc., raised a $5m Series A2 financing. Led by Neil Ray, MD, founder and CEO, Raydiant Oximetry is a San Ramon, CA USA-based clinical-stage medical device company focused on improving women’s and neonatal health. It is an investigational medical device that is not currently approved for commercial sale. The company intends to use the funds to complete a clinical study at the University of Texas Medical Branch (UTMB) in Galveston, Texas. The principal investigator for the study is Dr. George Saade, the Chief of Maternal Fetal Medicine at UTMB.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected